A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-42721458 in Healthy Male Participants
Clinical trial NCT01840501 · COMPLETED
Trial details
- NCT number
- NCT01840501
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-01
- Primary completion
- 2014-04-01
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.